Breakthrough pancreatic cancer drug nearly doubles survival in trial

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

Cancer vaccines based on mRNA advance, despite US cuts

Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting ...
MSN on MSN

New 'prevention vaccine' for people at high risk of bowel and ovarian cancer is announced

A revolutionary vaccine that could prevent cancer for people at high risk of bowel and ovarian cancer has been developed.

A 37-year-old woman's colon cancer symptom was dismissed as part of pregnancy. Months later, she was diagnosed with stage 4.

Gabby Zappia, 37, experienced blood in her stool during her third pregnancy. Months after giving birth, she learned she had ...

Dana-Farber Cancer Institute Receives Historic $50 Million Yawkey Foundation Grant

Farber Cancer Institute today announced that the Yawkey Foundation made a generous $50 million grant to support Dana-Farber's ...

Lung Cancer Research Foundation Announces Request for Proposals Open for ALK-Positive Lung Cancer Research Grant

The Lung Cancer Research Foundation announced today that a new, two-year, $300,000 research award focused on accelerating ...

The surprising ways exercise helps the body fight cancer

A landmark study suggests physical activity can help cancer patients live longer. Scientists are learning why.

Oxford University and Moderna launch trials of vaccine that could prevent cancer

A pioneering cancer vaccine, developed through a collaboration between the University of Oxford and pharmaceutical giant ...

The Hidden Toll of Surviving Bladder Cancer

For people with non–muscle invasive bladder cancer (NMIBC), the reality can be especially pronounced. The disease is often persistent, requiring repeated treatments, frequent monitoring, and ongoing ...